BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35619198)

  • 1. Reverse Liver Spleen Uptake on [ 68 Ga]Ga-PSMA-11 PET/CT.
    Abubakar S; Al Riyami K; Jain A; Jayakrishnan V; Tag N
    Clin Nucl Med; 2022 Dec; 47(12):1063-1065. PubMed ID: 35619198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frusemide aids diagnostic interpretation of
    Fennessy N; Lee J; Shin J; Ho B; Ali SA; Paschkewitz R; Emmett L
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):739-744. PubMed ID: 28623852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intense 68 Ga-PSMA Uptake in Neurofibroma Mimicking Cutaneous Metastases in a Patient With Prostate Cancer.
    Erol Fenercioğlu Ö; Beyhan E; Leblebici C; Arslan E; Çermik TF
    Clin Nucl Med; 2022 Oct; 47(10):e637-e639. PubMed ID: 35452001
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with
    Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S
    J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparison of [
    Wang G; Hong H; Zang J; Liu Q; Jiang Y; Fan X; Zhu Z; Zhu L; Kung HF
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1052-1062. PubMed ID: 34557930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ga-PSMA PET/CT Staging of Newly Diagnosed Intermediate- and High-Risk Prostate Cancer.
    Kuten J; Mabjeesh NJ; Lerman H; Levine C; Barnes S; Even-Sapir E
    Isr Med Assoc J; 2019 Feb; 21(2):100-104. PubMed ID: 30772960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vas Deferens and Inguinal Canal Metastasis of Prostate Cancer Revealed by 68 Ga-Prostate-Specific Membrane Antigen PET/CT.
    Erol Fenercioğlu Ö; Alçin G; Arslan E; Çermik TF; Ergül N
    Clin Nucl Med; 2022 Oct; 47(10):e635-e636. PubMed ID: 35439182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging.
    Demirci E; Sahin OE; Ocak M; Akovali B; Nematyazar J; Kabasakal L
    Nucl Med Commun; 2016 Nov; 37(11):1169-79. PubMed ID: 27333090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Sink Effect in
    Gafita A; Wang H; Robertson A; Armstrong WR; Zaum R; Weber M; Yagubbayli F; Kratochwil C; Grogan TR; Nguyen K; Navarro F; Esfandiari R; Rauscher I; Menze B; Elashoff D; Delpassand ES; Herrmann K; Czernin J; Hofman MS; Calais J; Fendler WP; Eiber M
    J Nucl Med; 2022 Feb; 63(2):226-232. PubMed ID: 34049987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual Case of Missed Penile Metastases on 68 Ga-PSMA PET/CT.
    Caputo SA; Blair G; Hawkins M; Harris K; Sartor O
    Clin Nucl Med; 2023 Aug; 48(8):710-711. PubMed ID: 37276530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective intra-individual blinded comparison of [
    Pattison DA; Debowski M; Gulhane B; Arnfield EG; Pelecanos AM; Garcia PL; Latter MJ; Lin CY; Roberts MJ; Ramsay SC; Thomas PA
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):763-776. PubMed ID: 34383089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Presentation of Liver Metastases of Prostate Cancer in 68Ga-PSMA-11 PET/CT.
    Stanzel S; Weitzer F; Janek E; Plhak E; Aigner RM
    Clin Nucl Med; 2023 Dec; 48(12):1064-1065. PubMed ID: 37934704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of optimal
    Wen J; Zhu Y; Li L; Liu J; Chen Y; Chen R
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2086-2095. PubMed ID: 34962583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography?
    Kulkarni SC; Sundaram PS; Padma S
    Nucl Med Commun; 2020 Feb; 41(2):139-146. PubMed ID: 31714366
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    De Man K; Van Laeken N; Schelfhout V; Fendler WP; Lambert B; Kersemans K; Piron S; Lumen N; Decaestecker K; Fonteyne V; Delrue L; De Vos F; Ost P
    Eur Urol; 2022 Nov; 82(5):501-509. PubMed ID: 35690515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the Staging/Restaging Performance of 68Ga-Labeled Prostate-Specific Membrane Antigen and 18F-Choline PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis.
    Lin CY; Lee MT; Lin CL; Kao CH
    Clin Nucl Med; 2019 May; 44(5):365-376. PubMed ID: 30888999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.